首页> 外文期刊>Journal of cellular and molecular medicine. >Ultrasound combined with SDF‐1α chemotactic microbubbles promotes stem cell homing in an osteoarthritis model
【24h】

Ultrasound combined with SDF‐1α chemotactic microbubbles promotes stem cell homing in an osteoarthritis model

机译:超声结合SDF-1α趋化微泡促进骨关节炎模型中的干细胞归巢

获取原文
           

摘要

Osteoarthritis (OA) is a common joint disease in the middle and old age group with obvious cartilage damage, and the regeneration of cartilage is the key to alleviating or treating OA. In stem cell therapy, bone marrow stem cell (BMSC) has been confirmed to have cartilage regeneration ability. However, the role of stem cells in promoting articular cartilage regeneration is severely limited by their low homing rate. Stromal cell‐derived factor‐1α (SDF‐1α) plays a vital role in MSC migration and involves activation, mobilization, homing and retention. So, we aim to develop SDF‐1α‐loaded microbubbles MB(SDF‐1α), and to verify the migration of BMSCs with the effect of ultrasound combined with MB(SDF‐1α) in vitro and in vivo. The characteristics of microbubbles and the content of SDF‐1α were examined in vitro. To evaluate the effect of ultrasound combined with chemotactic microbubbles on stem cell migration, BMSCs were injected locally and intravenously into the knee joint of the OA model, and the markers of BMSCs in the cartilage were detected. We successfully prepared MB(SDF‐1α) through covalent bonding with impressive SDF‐1α loading efficacy loading content. In vitro study, ultrasound combined with MB(SDF‐1α) group can promote more stem cell migration with highest migrating cell counts, good cell viability and highest CXCR4 expression. In vivo experiment, more BMSCs surface markers presented in the ultrasound combined with MB(SDF‐1α) group with or without exogenous BMSCs administration. Hence, ultrasound combined with MB(SDF‐1α) could promote the homing of BMSCs to cartilage and provide a novel promising therapeutic approach for OA.
机译:骨关节炎(OA)是中老年组的常见关节疾病,具有明显的软骨损伤,软骨再生是减轻或治疗OA的关键。在干细胞疗法中,已经证实骨髓干细胞(BMSC)具有软骨再生能力。然而,干细胞在促进关节软骨再生方面的作用严重限制了它们的宿舍。基质细胞衍生因子-1α(SDF-1α)在MSC迁移中起着至关重要的作用,并且涉及激活,动员,归巢和保留。因此,我们的目标是开发SDF-1α加载的微泡MB(SDF-1α),并验证BMSC的迁移,以在体外和体内中的超声组合MB(SDF-1α)。在体外检查微泡和SDF-1α的含量的特征。为了评估超声与趋化微泡的效果在干细胞迁移上,将BMSC局部和静脉内注射到OA模型的膝关节中,并检测软骨中BMSC的标记。我们通过与令人印象深刻的SDF-1α加载功效负载含量的共价键合成功地制备了MB(SDF-1α)。在体外研究中,超声组合MB(SDF-1α)组可以通过最高迁移细胞计数,良好的细胞活力和最高CXCR4表达促进更多的干细胞迁移。在体内实验中,超声中呈现的更多BMSCS表面标记与MB(SDF-1α)组联合,具有或没有外源BMSCs给药。因此,超声结合MB(SDF-1α)可以促进BMSCs归巢给软骨,并为OA提供一种有前途的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号